Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen replacement therapy: current recommendations.

E G Lufkin1, P C Carpenter, S J Ory

  • 1Division of Endocrinology/Metabolism and Internal Medicine, Mayo Clinic, Rochester, MN 55905.

Mayo Clinic Proceedings
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polycystic kidney disease: earlier diagnosis using ultrasound.

Urology·2011
Same author

Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.

Sarcoma·2008
Same author

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.

Gene therapy·2005
Same author

Cushing's syndrome due to medullary thyroid carcinoma: diagnosis by proopiomelanocortin messenger ribonucleic acid in situ hybridization.

The Journal of clinical endocrinology and metabolism·2003
Same author

Beyond one's everyday practice: worldwide women's health.

Current women's health reports·2002
Same author

Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study.

Cancer investigation·2001
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
See all related articles

Estrogen replacement therapy effectively prevents and treats postmenopausal osteoporosis, reducing fracture risk and alleviating menopausal symptoms. Benefits must be weighed against potential risks, with options to mitigate side effects.

Area of Science:

  • Reproductive Endocrinology
  • Gerontology
  • Pharmacology

Background:

  • Postmenopausal osteoporosis is a significant health concern, increasing fracture risk.
  • Menopausal symptoms like hot flushes and genitourinary issues impact quality of life.
  • Estrogen replacement therapy (ERT) is a potential intervention for these conditions.

Purpose of the Study:

  • To evaluate the efficacy of estrogen replacement therapy (ERT) for preventing and treating postmenopausal osteoporosis.
  • To assess the benefits of ERT in alleviating menopausal symptoms.
  • To weigh the advantages of ERT against its potential risks.

Main Methods:

  • The study reviews existing data on estrogen replacement therapy (ERT) for postmenopausal women.
  • It analyzes the effectiveness of ERT in preventing spinal compression fractures.

Related Experiment Videos

  • Potential risks such as endometrial hyperplasia, carcinoma, and other side effects are considered.

    • Main Results:

    • Estrogen replacement therapy (ERT) is effective for osteoporosis prevention and treatment, particularly for spinal fractures.
    • ERT alleviates menopausal symptoms including hot flushes, genitourinary issues, and mood changes.
    • Risks like endometrial hyperplasia can be reduced by adding progestin; transdermal preparations may minimize side effects.

    Conclusions:

    • Estrogen replacement therapy (ERT) should be considered for women post-menopause, especially those at high risk for osteoporosis.
    • The benefits of ERT, including fracture prevention and symptom relief, often outweigh the risks.
    • Initiating ERT soon after menopause is advisable and appears well-tolerated into older age.